Organic Active Ingredients TRIZ Cases

Cyclopentyl methyl ether crystallizes naltrexone base above 98% purity, resolving yield and time trade-offs in conventional solvent systems.

Composite carrageenan, xanthan gum, and starch maintain stable viscosity across temperatures to prevent choking in dysphagia nutrition.

Mebendazole and itraconazole inhibit smooth muscle cell proliferation to treat pulmonary hypertension without invasive surgery.

RNA from torula yeast mediates accurate DNA repair and eliminates damaged cells, resolving uncertainty about mutation prevention mechanisms.

A let-7f miRNA inhibitor reduces beta-agonist-mediated tachyphylaxis by targeting molecular pathways in airway cells.

Acyl-hydrazones inhibit tubulin to target leukemic cells, reducing toxicity to normal tissue compared with standard chemotherapeutic agents.

Modified benzodiazepine structures provide effective anti-RSV treatment across broader patient populations beyond high-risk infants.

AOL-conjugated TPP targets complex I to reduce ROS without impairing oxidative phosphorylation, resolving the trade-off between efficacy and cellular signaling.

Thioacids react with imides to synthesize nitrosporeusines A and B, overcoming scalability limits of existing antiviral drug production.

Sequential sodium hypochlorite and chlorhexidine cleaning removes pathogenic biofilms from tooth surfaces while preventing regrowth for 72 hours.

A bilayered tablet combines immediate and sustained layers to maintain effective serum levels of levodropropizine.

Natural pregnene glycosides inhibit appetite without side effects or dependence risks.

Dual D2 and D5 antagonism reduces side effects while maintaining therapeutic effectiveness.

A single methotrexate cycle reduces anti-drug antibodies and improves pharmacokinetics.

Pyrimidinylaminobenzene compounds overcome de novo resistance in non-small cell lung cancer with EGFR exon 20 insertions.

Selective breeding of scrapie-resistant ovine animals yields high GM1 ganglioside concentrations.

Controlled sulfonic acid hydrazide addition minimizes diimide gas evolution and avoids solvent distillation during hydrocodone synthesis.

Engineered T cell receptors target cancer cells expressing SSX-2 and SSX-3 antigens while sparing normal tissues to reduce off-target toxicity.

A non-PEGylated liposomal azithromycin formulation accumulates in injured myocardium to shift macrophage polarization toward reparative phenotypes.

A one-pot process for omarigliptin synthesis uses trifluoroacetic acid to remove Boc groups and perform reductive amination.

Formula I compounds inhibit HCV NS5B protein to resolve low virologic response and severe side effects in genotype 1 treatment.

Rebamipide reduces intestinal permeability by enhancing mucus barriers and restoring tight junctions, addressing strict gluten-free diet adherence challenges.

Buffering agents stabilize LMWH preparations against degradation under stress conditions.

Segmented therapy corrects cholesterol transport and STING silencing defects in Niemann-Pick Disease type C.

Amide derivatives inhibit the NLRP3 inflammasome with high specificity.

Combining low-dose interleukin-2 with hydroxychloroquine expands regulatory T cells to modulate the immune system.

Combining pharmacological intervention with behavioral therapy addresses neuronal causes of speech impairments, improving developmental outcomes.

Paricalcitol reduces erythropoiesis-stimulating agent requirements by optimizing iron metabolism and lowering hepcidin concentrations.

Crystalline L-lysine-d-amphetamine salts with adipic or fumaric acid partners reduce water uptake through modified crystal lattice structures.

Selective diazabicyclooctane inhibitors block pathological MMP activity, preserving the extracellular matrix and treating heart failure causes.

Cancer cell membrane-coated nanoparticles transport therapeutic agents across the blood-brain barrier.

A pharmaceutical composition combining GABA with incretins to promote beta-cell regeneration in diabetic subjects.

Mycophenolate mofetil treats drug-resistant influenza by blocking purine synthesis, bypassing conventional antiviral resistance mechanisms.

Leucine coating prevents moisture absorption in amino acids, avoiding granulation complexity and taste alteration.

Rapamycin subconjunctival injections with polyethylene glycol and ethanol extend corneal permeability to treat keratomycosis.

Covalently bonding heterocyclic compounds to serine residues on Ras mutant proteins reduces signaling output for undruggable oncogenic targets.

Composite Tsp-1 polypeptides merge anti-angiogenic and cytotoxic functions to overcome drug resistance in cancer therapy.

Combining JAK, ERK1/2, and SHP2 inhibitors overcomes resistance in myeloproliferative neoplasms by blocking parallel signaling pathways.

Isosteviol compounds enhance protein uptake in food compositions, resolving the trade-off between improved muscle mass and digestive issues.

A hydrochlorothiazide powder for oral suspension maintains stability and purity through pH control.

Targets covalently closed circular DNA persistence by recruiting helicase complexes via oligonucleotides.

Screen patient-derived glioblastoma stem cells against compound panels to identify effective treatments that prevent tumor recurrence.

A multilayered calcium phosphate nanoparticle uses a cationic polymer coating to enhance cellular uptake of active ingredients.

Novel crystalline forms of a P2Y12 receptor antagonist compound emerge through controlled precipitation in heterogeneous solvent systems.

Combines ripasudil with benzalkonium chloride to deliver potent antiseptic action in aqueous pharmaceutical formulations.

A transdermal patch delivers tizanidine through the skin via percutaneous absorption.